Newsletter

085660 - Chabiotech Co., Ltd.

085660 Summary
Biopharma
Stock Price & Overview
₩8,090 +170 (+2.15%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩8,090  ≈ US$6  ·  Market cap ₩0.8tn (≈ $537m)
What kstock news is. Short items on what actually happened — a filing, an order, a buyback, a result — written from the Korean filing or the Korean press for people who cannot read either. Each one puts the event against a figure from this company's own statements. No view, no rating; that is what analysis is for.

085660 News

All kstock news »
ks

Chabiotech Co., Ltd. Joins Government Cell Therapy Quality Research Project - Newsis

Chabiotech Co., Ltd. (085660) was selected for a government backed cell and gene therapy quality research project.

kstock NewsToday, 7:19 PM
1 item. Written from DART filings and Korean press reports; every item lists its source.

Similar to 085660

SymbolLast Price
185750Chong Kun Dang Pharmaceutical Corp.₩68,000
-0.3%
115180Qurient Co., Ltd.₩23,050
+17.3%
476830Rznomics, Inc.₩28,200
+6.8%
003850Boryung Corporation₩9,040
+1.6%
950260Ingenia Therapeutics Inc.(reg.s)₩15,580
-1.5%
476060Onconic Therapeutics, Inc.₩16,440
-3.9%
041960Komipharm International Co., Ltd.₩9,710
+3.5%
317450Myungin Pharm₩44,650
+0.0%
001060JW Pharmaceutical₩27,500
+1.3%
456160G2GBIO, Inc.₩37,950
+5.7%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.